Previous research has established that the primary cause of NSCLC is often mutations in the EGFR gene, which result in excessive intracellular signaling and uncontrolled cancer cell proliferation, as well as the development of resistance to EGFR-targeted therapies [18,19]. The gene discussed is EGFR; the disease is cancer.